ACRO BIOMEDICAL CO., LTD. (ACBM)

Every figure this model derived for ACBM, the value it took, and the element in the company's own XBRL it was read from — so any of it can be checked against the filing rather than taken on trust. As at 2026-06-30.

The figures, and where each came from

This is the part no other screener shows. Each figure below names the XBRL element it was read from, so it can be checked against the filing itself.

FigureValueXBRL tagAs at
cash 3,648 CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents 2026-06-30
current assets 3,648 AssetsCurrent 2026-06-30
current liabilities 448,437 LiabilitiesCurrent 2026-06-30
equity -444,789 StockholdersEquity 2026-06-30
interest expense 0 InterestPaidNet 2026-06-30
ocf -140,112 NetCashProvidedByUsedInOperatingActivities 2026-06-30
revenue 0 Revenues 2026-06-30
sbc 0 ShareBasedCompensation 2024-12-31

The ratios

The figures themselves rather than their scores — what somebody looking up ACBM on one particular measure came for.

RatioValue
current ratio0.01
current ratio reported0.01
deferred revenue growth-100.0
dilution pct0.0
growth cv7.75

What to be careful about

What this model itself distrusts about ACBM's figures. Written by the derivation as it ran, not added afterwards.